GLP-1 is an enteric insulin-secreting molecule used in the treatment of T2DM because of its properties, such as causing central appetite suppression, protection of pancreatic islet β-cells, and cardiovascular protective effects [47]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.